Haemonetics (HAE): CSL plans full US NexSys rollout by end of 2027
CSL now expects to move all its current US plasma centers to Haemonetics' NexSys devices by end-2027, up from "a portion" with no timeline in August…
Home/Companies/Haemonetics (HAE)
Haemonetics (HAE)
1 take
All Centiview takes on Haemonetics (ticker HAE): earnings, deals and market news, newest first. Filed under Healthcare; region: US. Each take lists its sources. For information only, not advice.